AU2001264044A1 - 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof - Google Patents
1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereofInfo
- Publication number
- AU2001264044A1 AU2001264044A1 AU2001264044A AU6404401A AU2001264044A1 AU 2001264044 A1 AU2001264044 A1 AU 2001264044A1 AU 2001264044 A AU2001264044 A AU 2001264044A AU 6404401 A AU6404401 A AU 6404401A AU 2001264044 A1 AU2001264044 A1 AU 2001264044A1
- Authority
- AU
- Australia
- Prior art keywords
- nonabenzoxazole
- benzothiazole
- diazabicyclo
- preparation
- therapeutic use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- FTTATHOUSOIFOQ-UHFFFAOYSA-N 1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine Chemical compound C1NCCN2CCCC21 FTTATHOUSOIFOQ-UHFFFAOYSA-N 0.000 title 1
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0006975 | 2000-05-31 | ||
| FR0006975A FR2809730B1 (en) | 2000-05-31 | 2000-05-31 | 1,4-DIAZABICYCLO [3.2.2] NONANEBENZOXAZOLE, -BENZOTHIAZOLE AND -BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| PCT/FR2001/001651 WO2001092261A1 (en) | 2000-05-31 | 2001-05-29 | 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001264044A1 true AU2001264044A1 (en) | 2001-12-11 |
Family
ID=8850826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001264044A Abandoned AU2001264044A1 (en) | 2000-05-31 | 2001-05-29 | 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7220740B2 (en) |
| EP (1) | EP1289988B1 (en) |
| JP (1) | JP4939721B2 (en) |
| AR (1) | AR028647A1 (en) |
| AT (1) | ATE267202T1 (en) |
| AU (1) | AU2001264044A1 (en) |
| DE (1) | DE60103395T2 (en) |
| FR (1) | FR2809730B1 (en) |
| HU (1) | HU229102B1 (en) |
| TW (1) | TW541307B (en) |
| WO (1) | WO2001092261A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0000540D0 (en) | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
| US20020086871A1 (en) * | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
| DE60215172T2 (en) * | 2001-07-06 | 2007-08-30 | Neurosearch A/S | NEW COMPOUNDS, THEIR PREPARATION AND USE |
| FR2832714B1 (en) | 2001-11-23 | 2004-07-16 | Sanofi Synthelabo | DERIVATIVES OF 4- (OXAZOLOPYRIDIN-2-YL) -1,4-DIAZABICYCLO [3.2.2] NONANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| SE0202465D0 (en) * | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | New compounds |
| US7456171B2 (en) | 2002-10-08 | 2008-11-25 | Sanofi-Aventis | 1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof |
| FR2845388B1 (en) * | 2002-10-08 | 2004-11-12 | Sanofi Synthelabo | 1,4-DIAZABICYCLO [3.2.2] NONANECARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| US7223753B2 (en) | 2002-11-11 | 2007-05-29 | Neurosearch A/S | Diazabicyclic biaryl derivatives |
| AU2003280309A1 (en) * | 2002-11-11 | 2004-06-03 | Neurosearch A/S | 1,4-diazabicyclo (3,2,2)nonane derivatives, preparation and therapeutical use thereof |
| NZ540998A (en) * | 2003-02-27 | 2008-06-30 | Neurosearch As | Novel diazabicyclic aryl derivatives |
| FR2865208B1 (en) * | 2004-01-16 | 2009-01-16 | Sanofi Synthelabo | 1,4-DIAZABICYCLO [3.2.1] OCTANECARBOXMIQUE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF |
| DE602005018020D1 (en) | 2004-02-04 | 2010-01-14 | Neurosearch As | DIAZABICYCLIC ARYL DERIVATIVES AS CHOLINERGE RECEPTOR MODULATORS |
| JP2008519820A (en) * | 2004-11-15 | 2008-06-12 | ファイザー・プロダクツ・インク | Azabenzoxazole for the treatment of CNS disorders |
| WO2006051410A1 (en) * | 2004-11-15 | 2006-05-18 | Pfizer Inc. | Azabenzoxazoles for the treatment of cns disorders |
| WO2006051413A1 (en) * | 2004-11-15 | 2006-05-18 | Pfizer Inc. | Azabenoxazoles for the treatment of cns disorders |
| US7662812B2 (en) | 2005-02-16 | 2010-02-16 | Neurosearch A/S | Diazabicyclic aryl derivatives and their use as chinolinergic ligands at nicotinic acetylcholine receptors |
| EP2029607A1 (en) | 2006-05-23 | 2009-03-04 | NeuroSearch A/S | Novel 8,10-diaza-bicycloý4.3.1¨decane derivatives and their medical use |
| CN104262348B (en) * | 2014-08-15 | 2017-12-15 | 北京师范大学 | A kind of alpha 7 nicotinic acetylcholine receptors part and preparation method thereof |
| CN107188900B (en) * | 2017-05-27 | 2019-09-06 | 北京师范大学 | Ligand compound of α7 nicotinic acetylcholine receptor and its application |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN166416B (en) * | 1985-09-18 | 1990-05-05 | Pfizer | |
| NZ226000A (en) * | 1987-09-10 | 1991-06-25 | Merck Sharp & Dohme | Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions |
| US5478939A (en) * | 1994-07-20 | 1995-12-26 | American Cyanamid Company | (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives |
| FR2786770B1 (en) | 1998-12-04 | 2001-01-19 | Synthelabo | NONANE 1,4-DIAZABICYCLO [3.2.2.] DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| US20020086871A1 (en) * | 2000-12-29 | 2002-07-04 | O'neill Brian Thomas | Pharmaceutical composition for the treatment of CNS and other disorders |
-
2000
- 2000-05-31 FR FR0006975A patent/FR2809730B1/en not_active Expired - Fee Related
-
2001
- 2001-05-29 EP EP01938363A patent/EP1289988B1/en not_active Expired - Lifetime
- 2001-05-29 JP JP2002500874A patent/JP4939721B2/en not_active Expired - Fee Related
- 2001-05-29 HU HU0302193A patent/HU229102B1/en not_active IP Right Cessation
- 2001-05-29 AT AT01938363T patent/ATE267202T1/en not_active IP Right Cessation
- 2001-05-29 WO PCT/FR2001/001651 patent/WO2001092261A1/en not_active Ceased
- 2001-05-29 AU AU2001264044A patent/AU2001264044A1/en not_active Abandoned
- 2001-05-29 DE DE60103395T patent/DE60103395T2/en not_active Expired - Lifetime
- 2001-05-29 US US10/276,646 patent/US7220740B2/en not_active Expired - Lifetime
- 2001-05-30 AR ARP010102574A patent/AR028647A1/en active IP Right Grant
- 2001-05-30 TW TW090113060A patent/TW541307B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003535091A (en) | 2003-11-25 |
| AR028647A1 (en) | 2003-05-21 |
| HUP0302193A2 (en) | 2003-11-28 |
| EP1289988B1 (en) | 2004-05-19 |
| TW541307B (en) | 2003-07-11 |
| ATE267202T1 (en) | 2004-06-15 |
| FR2809730A1 (en) | 2001-12-07 |
| US7220740B2 (en) | 2007-05-22 |
| HU229102B1 (en) | 2013-07-29 |
| FR2809730B1 (en) | 2002-07-19 |
| EP1289988A1 (en) | 2003-03-12 |
| US20030153574A1 (en) | 2003-08-14 |
| WO2001092261A1 (en) | 2001-12-06 |
| HUP0302193A3 (en) | 2012-02-28 |
| DE60103395D1 (en) | 2004-06-24 |
| DE60103395T2 (en) | 2005-06-16 |
| JP4939721B2 (en) | 2012-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03000753A (en) | Benzimidazole derivatives, preparation and therapeutic use thereof. | |
| AU2002340999A1 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
| AU1393000A (en) | 1,4-diazabicyclo(3.2.2)nonane derivatives, their preparation and therapeutic application | |
| HRP20040027A2 (en) | 1-phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
| AU3957600A (en) | Piperidyl-imidazole derivatives, their preparations and therapeutic uses | |
| AU2001264044A1 (en) | 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof | |
| AU2922600A (en) | Pyridopyranoazepine derivatives, preparation and therapeutic use | |
| AU2002359126A1 (en) | Benzodiazepine derivatives, preparation thereof and use thereof | |
| AU2001264042A1 (en) | 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof | |
| AU2002359123A1 (en) | Benzodiazepine derivatives, preparation thereof and use thereof | |
| AU2001235595A1 (en) | 4-heteroaryl-1,4-diazabicyclo(3.2.2)nonane, preparation and therapeutic use thereof | |
| HUP0105039A3 (en) | Fungicidal propargylether derivatives, preparation and use thereof | |
| ZA200003706B (en) | Cyclobutene derivatives, their preparation and their therapeutic uses. | |
| TWI318974B (en) | Acylaminothiazole derivatives, their preparation and their therapeutic use | |
| ZA200001746B (en) | 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use. | |
| TWI320413B (en) | 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof | |
| AU3971500A (en) | Indazole derivatives, preparation and therapeutic application thereof | |
| AU2001284084A1 (en) | Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof | |
| MXPA03006162A (en) | Mikanolide derivatives, their preparation and therapeutic uses. | |
| AU2002229870A1 (en) | Mikanolide derivatives, their preparation and therapeutic uses | |
| ZA200001747B (en) | 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use. | |
| IL161859A0 (en) | 3-Heteroaryl-3.5-dihydro-4-oxo-4H-pyridazinoÄ4.5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use | |
| AU2001237518A1 (en) | Polyfluoroalkylimidazole derivatives, their preparation and therapeutic application | |
| AU2001278550A1 (en) | 1-(4-oxo-3,5-dihydro-4h-pyridazino(4,5-b)indole-1-carbonyl (piperazine) derivatives, their preparation and therapeutic application | |
| IL149653A0 (en) | 2-arylquinoline derivatives, preparation and therapeutic use thereof |